#PortfolioNews | SpliceBio doses the first patient in the Phase 1/2 ASTRA study of SB-007, the first dual AAV #GeneTherapy for #StargardtDisease!
🎯 Showcasing the power of #ProteinSplicing to tackle diseases caused by #LargeGenes mutations.
👉 buff.ly/HvB3bPR
#VC
🎯 Showcasing the power of #ProteinSplicing to tackle diseases caused by #LargeGenes mutations.
👉 buff.ly/HvB3bPR
#VC
March 13, 2025 at 2:27 PM
#PortfolioNews | SpliceBio doses the first patient in the Phase 1/2 ASTRA study of SB-007, the first dual AAV #GeneTherapy for #StargardtDisease!
🎯 Showcasing the power of #ProteinSplicing to tackle diseases caused by #LargeGenes mutations.
👉 buff.ly/HvB3bPR
#VC
🎯 Showcasing the power of #ProteinSplicing to tackle diseases caused by #LargeGenes mutations.
👉 buff.ly/HvB3bPR
#VC